Funding for this research was provided by:
Taiwan Santen Pharmaceutical Co., Ltd. (Taiwan Santen Pharmaceutical Co., Ltd.)
Article History
Received: 10 June 2024
Accepted: 22 December 2024
First Online: 8 March 2025
Declarations
:
: The authors declare the following potential conflicts of interest: This study received funding from Taiwan Santen Pharmaceutical Co., Ltd., which covered expenses related to administrative processes, data management, statistical analysis, and manuscript preparation. The funding agreement ensured the investigators’ independence in designing the study; collecting, analyzing, and interpreting the data; and writing and publishing the report. No other financial or nonfinancial conflicts of interest related to this research exist.